10578 Science Center Drive
San Diego, CA 92121
(858) 625 2424
5 Sylvan Way
Parsippany, NJ 07054
(973) 254 3560
DepoCyt(e)® (cytarabine liposome injection) is a sustained-release liposomal formulation of the chemotherapeutic agent cytarabine utilizing Pacira's DepoFoam® technology.
As opposed to conventional cytarabine, which is administered in the hospital twice weekly by spinal injection, DepoCyt(e) extends the duration of cytarabine efficacy to allow for injection once every two weeks in an outpatient setting.
IMPORTANT SAFETY INFORMATION for DepoCyt(e)
To report an adverse event, e-mail email@example.com, dial 1-855-397-2467,
For medical inquiries related to DepoCyt, contact Medical Information at firstname.lastname@example.org or 1-855-397-2467,
Lymphomatous meningitis (LM) is cancer that started as primary lymphoma and has spread to the lining of the spinal cord and brain (this lining is the meninges). LM is reported in 5% to 15% of patients with diffuse high-grade non-Hodgkin’s lymphoma.
LM is rarely curable. However, research has shown that treatment that starts soon after the disease is detected can help many patients. In some patients, early treatment can prevent or slow worsening of symptoms caused by growth of cancer in the meninges.
For more information or questions related to the availability of DepoCyt® in the United States or DepoCyte® in Europe, please contact our marketing and distribution partners Sigma-Tau or Mundipharma.